Aadi Bioscience, Inc. (AADI)

Balance Sheet (Trailing)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Quarter Ending	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31
Cash & Equivalents	129.85	148.99	161.38	36.84	39.03	4.46	47.3	44.88	34.6	38.56	43.43	48.2	53.46	62.65	68.83	68.8	13.78	20.29	24.85	28.87	35.16	1.63	-	-	-	0.02
Short-Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.05	0.05	0.05	0.05	-	-	-	0
Cash & Cash Equivalents	129.85	148.99	161.38	36.84	39.03	4.46	47.3	44.88	34.6	38.56	43.43	48.2	53.46	62.65	68.83	68.8	13.78	20.29	24.9	28.92	35.21	1.68	0	0	0	0.02
Cash Growth	232.70%	3244.31%	241.16%	-17.93%	12.78%	-88.45%	8.91%	-6.88%	-35.27%	-38.45%	-36.90%	-29.95%	287.85%	208.87%	176.42%	137.92%	-60.85%	1106.97%	-	-	-	8970.40%	-	-	-	-
Receivables	2.71	0	0	0	0	14.15	0	0	0	0	0	0	0	0	0	0	0	0	0.04	0	0.03	0	-	-	-	0
Inventory	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	0
Other Current Assets	2.86	2.28	0.64	0.56	1.97	0.08	2.28	0.55	0.79	1.01	1.37	0.59	0.84	1.33	1.21	0.62	0.83	0.61	0.92	0.72	0.88	0.54	-	-	-	0
Total Current Assets	135.62	151.27	162.02	37.39	41	18.69	49.58	45.43	35.39	39.57	44.8	48.79	54.3	63.98	70.04	69.43	14.61	20.9	25.86	29.64	36.12	2.23	-	-	-	0.02
Property, Plant & Equipment	0.62	0.61	0.61	0.01	0.14	0.14	0.23	0.26	0.29	0.33	0.71	0.77	0.72	0.1	0.1	0.09	0.1	0.11	0.12	0.13	0.14	0.15	-	-	-	0
Goodwill and Intangibles	3.74	3.81	3.88	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	0
Other Long-Term Assets	2.34	2.21	2.26	0.02	0.02	0	0.02	0.02	0.02	0.04	0.04	0.04	0.04	0.04	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	-	-	-	-
Total Long-Term Assets	6.7	6.64	6.75	0.03	0.16	0.14	0.25	0.28	0.31	0.37	0.75	0.81	0.76	0.14	0.12	0.11	0.12	0.13	0.14	0.15	0.16	0.17	-	-	-	0
Total Assets	142.32	157.91	168.77	37.42	41.16	18.83	49.83	45.72	35.7	39.94	45.55	49.6	55.06	64.12	70.16	69.54	14.73	21.03	26	29.79	36.28	2.4	-	-	-	0.02
Accounts Payable	9.77	12.2	10.98	2.2	2.09	16.71	2.42	2.99	2.55	3.23	3.4	3.4	3.73	5.46	3.64	2.97	3.62	3.59	2.59	1.86	2.97	2.47	-	-	-	0
Deferred Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.67	0	0	0	0	0	0	-	-	-	0
Current Debt	0.16	0.13	0.09	0.01	0.04	9.15	0.09	0.11	0.11	0.1	0.2	0.19	0.19	0	0	0	0	0	0	0	0	12.39	-	-	-	0.16
Other Current Liabilities	1.58	2.95	0.49	0	0	4.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	0.04
Total Current Liabilities	11.51	15.27	11.57	2.21	2.13	30.06	2.51	3.11	2.65	3.33	3.6	3.6	3.92	5.46	3.64	21.63	3.62	3.59	2.59	1.86	2.97	14.86	-	-	-	0.21
Long-Term Debt	0.42	0.47	0.52	0	0	1.1	0	0.01	0.04	0.07	0.24	0.29	0.34	0	0	0	0	0	0	0	0	0	-	-	-	0
Other Long-Term Liabilities	5.76	5.76	5.76	-	-	0.1	-	0	0	0	0	0	0	-	-	-	-	-	-	-	-	73.76	-	-	-	-
Total Long-Term Liabilities	6.18	6.23	6.28	0	0	1.2	0	0.01	0.04	0.07	0.24	0.29	0.34	0	0	0	0	0	0	0	0	73.76	-	-	-	0
Total Liabilities	17.69	21.5	17.85	2.21	2.13	31.26	2.51	3.12	2.69	3.4	3.84	3.88	4.26	5.46	3.64	21.63	3.62	3.59	2.59	1.86	2.97	88.62	-	-	-	0.21
Total Debt	0.59	0.61	0.61	0.01	0.04	10.26	0.09	0.12	0.15	0.17	0.43	0.48	0.53	0	0	0	0	0	0	0	0	12.39	-	-	-	0.16
Debt Growth	1398.56%	-94.10%	546.71%	-91.77%	-73.15%	5933.19%	-78.13%	-74.86%	-72.33%	-	-	-	-	-	-	-	-	-	-	-	-	7641.65%	-	-	-	-
Common Stock	281.17	279.09	277.62	190.62	190.02	20.16	189.15	179.48	179.16	178.77	179.5	178.86	178.25	177.63	176.96	169.88	127.1	126	125.74	125.62	125.47	0	0	0	0	0.05
Retained Earnings	-156.54	-142.69	-126.7	-155.4	-150.99	-32.6	-141.83	-136.88	-146.15	-142.24	-137.79	-133.14	-127.46	-118.96	-110.44	-121.98	-115.99	-108.56	-102.33	-97.68	-92.16	-86.22	-	-	-	-0.24
Shareholders' Equity	124.63	136.41	150.93	35.22	39.03	-12.43	47.32	42.6	33.01	36.54	41.71	45.72	50.8	58.67	66.52	47.91	11.11	17.44	23.42	27.94	33.31	-86.22	-	-	-	-0.19
Total Liabilities and Equity	142.32	157.91	168.77	37.42	41.16	18.83	49.83	45.72	35.7	39.94	45.55	49.6	55.06	64.12	70.16	69.54	14.73	21.03	26	29.79	36.28	2.4	0	0	0	0.02
Net Cash / Debt	129.26	148.38	160.76	36.83	38.99	-5.8	47.21	44.76	34.46	38.39	43	47.72	52.94	62.65	68.83	68.8	13.78	20.29	24.9	28.92	35.21	-10.71	0	0	0	-0.14
Net Cash / Debt Growth	231.53%	-	240.55%	-17.73%	13.15%	-	9.79%	-6.19%	-34.91%	-38.72%	-37.53%	-30.65%	284.02%	208.87%	176.42%	137.92%	-60.85%	-	-	-	-	-	-	-	-	-
Net Cash Per Share	6.18	16.63	16.90	11.66	15.34	-2.28	18.57	16.54	12.73	14.19	15.89	17.63	19.56	27.70	25.47	37.75	7.65	14.04	13.87	16.13	94.23	-188.34	-	-	-	-0.42
Working Capital	124.11	136	150.45	35.19	38.87	-11.37	47.07	42.33	32.74	36.24	41.2	45.19	50.38	58.53	66.39	47.79	10.99	17.31	23.28	27.79	33.15	-12.63	-	-	-	-0.19
Book Value Per Share	5.96	15.29	15.87	11.15	15.35	-4.89	18.61	15.74	12.20	13.50	15.42	16.89	18.77	25.93	24.62	26.28	6.16	12.07	13.04	15.58	89.14	-1.00	-	-	-	-0.56

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).